肺结核自然史再评估:贝叶斯估计自然康复与死亡率
该研究基于化疗前时代41个涂阳和19个涂阴肺结核队列,用贝叶斯框架估计结核特异死亡率和自愈率。涂阳结核死亡率为0.389/年,涂阴为0.025/年,相差约15倍;自愈率分别为0.231/年和0.130/年。涂阴结核虽传染性较低,但因病程更长可能产生相似数量的继发感染。
要点
- 涂阳肺结核结核特异死亡率约0.389/年,涂阴约0.025/年,相差约15倍。
- 涂阳和涂阴肺结核自愈率分别为0.231/年和0.130/年。
- 涂阴肺结核病程更长,可能产生与涂阳相似的继发感染数。
核心结论
- 涂阳肺结核的结核特异死亡率约为涂阴的15倍。
- 既往结核建模研究严重低估了这一差异,相关预测准确性存疑。
- 涂阴肺结核虽传染性较低,但因病程更长可能产生同等数量的继发感染。
研究设计与样本
- 基于先前系统综述中的化疗前时代研究,提取随时间变化的死亡率详细数据。
- 采用贝叶斯框架估计结核所致死亡率和自愈率。
- 使用分层模型允许估计值随队列变化。
- 分别对涂阳肺结核和涂阴肺结核进行推断。
- 纳入41个涂阳肺结核患者队列和19个涂阴肺结核患者队列。
主要发现
- 假设非结核相关死亡率为0.014/年(即70年预期寿命),涂阳和涂阴肺结核未治疗平均病程分别为1.57年(95%可信区间1.37-1.81)和5.35年(95%可信区间3.42-8.23)。
临床怎么用
- 临床医生应认识到涂阳肺结核的结核特异死亡风险远高于涂阴肺结核。
- 涂阴肺结核因病程长,可能持续传播,需重视其公共卫生影响。
局限性
- 研究基于化疗前时代数据,可能不完全适用于现代医疗环境。
- 研究纳入的队列来自先前系统综述,可能存在选择偏倚。
- 研究假设非结核相关死亡率为固定值0.014/年,可能影响病程估计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tuberculosis (TB) natural history remains poorly characterized, and new investigations are impossible as it would be unethical to follow up TB patients without treatment. METHODS: We considered the reports identified in a previous systematic review of studies from the prechemotherapy era, and extracted detailed data on mortality over time. We used a Bayesian framework to estimate the rates of TB-induced mortality and self-cure. A hierarchical model was employed to allow estimates to vary by cohort. Inference was performed separately for smear-positive TB (SP-TB) and smear-negative TB (SN-TB). RESULTS: We included 41 cohorts of SP-TB patients and 19 cohorts of pulmonary SN-TB patients in the analysis. The median estimates of the TB-specific mortality rates were 0.389 year-1 (95% credible interval [CrI], .335-.449) and 0.025 year-1 (95% CrI, .017-.035) for SP-TB and SN-TB patients, respectively. The estimates for self-recovery rates were 0.231 year-1 (95% CrI, .177-.288) and 0.130 year-1 (95% CrI, .073-.209) for SP-TB and SN-TB patients, respectively. These rates correspond to average durations of untreated TB of 1.57 years (95% CrI, 1.37-1.81) and 5.35 years (95% CrI, 3.42-8.23) for SP-TB and SN-TB, respectively, when assuming a non-TB-related mortality rate of 0.014 year-1 (ie, a 70-year life expectancy). CONCLUSIONS: TB-specific mortality rates are around 15 times higher for SP-TB than for SN-TB patients. This difference was underestimated dramatically in previous TB modeling studies, raising concerns about the accuracy of the associated predictions. Despite being less infectious, SN-TB may be responsible for equivalent numbers of secondary infections as SP-TB due to its much longer duration.
引用
- Ragonnet R, Flegg JA, Brilleman SL, et al. Revisiting the Natural History of Pulmonary Tuberculosis: A Bayesian Estimation of Natural Recovery and Mortality Rates. Clin Infect Dis. 2021. PMID: 32766718. doi:10.1093/cid/ciaa602
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。